Sofpromed is a full service contract research organization (CRO) specialized in the integral management of phase I-IV clinical trials and observational studies in oncology. The company provides regulatory, site management, monitoring, data management, pharmacovigilance, and medical writing services for the pharmaceutical and biotechnology industries. Main therapeutic areas include solid tumors (soft-tissue sarcomas, bone tumors, gastrointestinal, endometrial, ovarian, breast, and lung cancer), hematologic malignancies (leukemia and lymphomas), and rare cancers.